Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

5-fluorouracil

  • You have access
    NFκB-Associated Pathways in Progression of Chemoresistance to 5-Fluorouracil in an In Vitro Model of Colonic Carcinoma
    MARIA ISABEL KÖRBER, ANNA STARIBACHER, INA RATZENBÖCK, GÜNTHER STEGER and ROBERT M. MADER
    Anticancer Research April 2016, 36 (4) 1631-1639;
  • You have access
    Early Response of Esophageal Cancer to Neoadjuvant Chemotherapy with Docetaxel–Cisplatin–5-Fluorouracil Represents Sensitivity: A Phase II Study
    AKIRA MATSUMOTO, KATSUNORI NISHIKAWA, MASAMI YUDA, YUJIRO TANAKA, YUICHIRO TANISHIMA, YASUHIRO ARAKAWA, YOSHIO ISHIBASHI, TOSHIKAZU SAKUYAMA, NOBUO OMURA, NORIO MITSUMORI, KEISUKE AIBA and KATSUHIKO YANAGA
    Anticancer Research April 2016, 36 (4) 1937-1942;
  • You have access
    Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance
    JAMIE N. HADAC, DEVON D. MILLER, IAN C. GRIMES, LINDA CLIPSON, MICHAEL A. NEWTON, WILLIAM R. SCHELMAN and RICHARD B. HALBERG
    Anticancer Research March 2016, 36 (3) 845-852;
  • You have access
    Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma
    MASANORI KOMATSU, YASUHIRO ARAI, KENICHIRO YABUKI, DAISUKE SANO, OSAMU SHIONO, YASUNORI SAKUMA, GOUSHI NISHIMURA, MASAHIRO TAKAHASHI, TAKAHIDE TAGUCHI and NOBUHIKO ORIDATE
    Anticancer Research December 2015, 35 (12) 6861-6867;
  • You have access
    Investigation of Potentially Deleterious Alleles for Response to Cancer Treatment with 5-Fluorouracil
    GIOVANNA CHAVES CAVALCANTE, NATALLE DO SOCORRO DA COSTA FREITAS, ANDRÉ MAURÍCIO RIBEIRO-DOS-SANTOS, DARLEN CARDOSO DE CARVALHO, ELLEN MORENO DA SILVA, PAULO PIMENTEL DE ASSUMPÇÃO, ÂNDREA RIBEIRO-DOS-SANTOS, SIDNEY SANTOS and NEY PEREIRA CARNEIRO DOS SANTOS
    Anticancer Research December 2015, 35 (12) 6971-6977;
  • You have access
    5-Fluorouracil Chemotherapy for Dihydropyrimidine Dehydrogenase-deficient Patients: Potential of the Dose-escalation Method
    YOICHIRO YOSHIDA, KENICHIRO OGURA, AKIRA HIRATSUKA, NAOYA AISU, TEPPEI YAMADA, DAIBO KOJIMA, SYU TANIMURA, KENTARO OGATA, SHUUJI HARA, AI MOGI, YASUSHI TAKAMATSU, KAZUO TAMURA, HIDEYUKI MISHIMA and YUICHI YAMASHITA
    Anticancer Research September 2015, 35 (9) 4881-4887;
  • You have access
    Immunogenic Modulation of Cholangiocarcinoma Cells by Chemoimmunotherapy
    SHIGEO KOIDO, SHIN KAN, KOSAKU YOSHIDA, SHINJI YOSHIZAKI, KAZUKI TAKAKURA, YOSHIHISA NAMIKI, SHINTARO TSUKINAGA, SHUNICHI ODAHARA, MIKIO KAJIHARA, MASATO OKAMOTO, MASAKI ITO, SEI-ICHI YUSA, JIANLIN GONG, HARUO SUGIYAMA, TOSHIFUMI OHKUSA, SADAMU HOMMA and HISAO TAJIRI
    Anticancer Research November 2014, 34 (11) 6353-6361;
  • You have access
    Genistein Potentiates the Antitumor Effect of 5-Fluorouracil by Inducing Apoptosis and Autophagy in Human Pancreatic Cancer Cells
    REI SUZUKI, YA'AN KANG, XINQUN LI, DAVID ROIFE, RAN ZHANG and JASON B. FLEMING
    Anticancer Research September 2014, 34 (9) 4685-4692;
  • You have access
    The Synergistic Effect of Rapamycin Combined with 5-Fluorouracil in BALB/cByJNarl Mice Bearing CT-26 Tumor Cells
    TE-HSIN CHAO, GENG-RUEI CHANG, WEN-YING CHEN, PO-LIN CHEN and FRANK CHIAHUNG MAO
    Anticancer Research July 2014, 34 (7) 3329-3335;
  • You have access
    3’-Deoxy-3’-[18F]Fluorothymidine Positron Emission Tomography Imaging of Thymidine Kinase 1 Activity After 5-Fluorouracil Treatment in a Mouse Tumor Model
    IL KI HONG, SEOG YOUNG KIM, JIN HWA CHUNG, SEUNG JIN LEE, SEUNG JUN OH, SANG JU LEE, JUNGSU OH, JIN-SOOK RYU, TAE WON KIM, DEOG YOON KIM and DAE HYUK MOON
    Anticancer Research February 2014, 34 (2) 759-766;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire